Search Within

Adult Leukemia

Formats
  1. Meeting Abstract (1797)
  2. Journal Article (1603)
  3. Review (122)
  4. Research Letter (55)
  5. Editorial (49)
  6. Book Section (39)
  7. Guidelines (20)
  8. Conference Paper (18)
  9. Correspondence (13)
  10. Miscellaneous (3)
  11. Book Whole (1)
Groups
  1. Center for Hematologic Malignancies (3720)
  2. Department of Medicine (3689)
  3. Hematologic Malignancies, Division of (3685)
  4. GSK Faculty (1783)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (1378)
  6. Executive Committee, Center for Hematologic Malignancies (970)

More Groups

People
  1. Ross Levine (787)
  2. Martin Tallman (655)
  3. David Scheinberg (502)
  4. Jae Park (387)
  5. Eytan Stein (371)
  6. Raajit Rampal (352)

More People

Years
  1. 2025 (103)
  2. 2024 (196)
  3. 2023 (233)
  4. 2022 (255)
  5. 2021 (248)
  6. 2020 (273)

More Years

Publications
  1. Blood (1254)
  2. Journal of Clinical Oncology (217)
  3. Clinical Lymphoma, Myeloma and Leukemia (117)
  4. Leukemia (110)
  5. Haematologica (107)
  6. Cancer Research (86)

More Publications

Publishers
  1. American Society of Hematology (1345)
  2. Nature Publishing Group (324)
  3. Elsevier Inc. (255)
  4. American Association for Cancer Research (234)
  5. American Society of Clinical Oncology (230)
  6. Ferrata Storti Foundation (107)

More Publishers

Results (3720)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Real-world outcomes and management strategies for venetoclax-treated chronic lymphocytic leukemia patients in the United States
    Journal Article

    Mato, A. R.; Thompson, M.; Allan, J. N.; Brander, D. M.; Pagel, J. M.; Ujjani, C. S.; Hill, B. T.; Lamanna, N.; Lansigan, F.; Jacobs, R.; more...
    Haematologica (2018)

    Fulltext@MSK | Save
  • Clinical and biological correlates of neurotoxicity associated with CAR T-cell therapy in patients with B-cell acute lymphoblastic leukemia
    Journal Article

    Santomasso, B. D.; Park, J. H.; Salloum, D.; Riviere, I.; Flynn, J.; Mead, E.; Halton, E.; Wang, X.; Senechal, B.; Purdon, T.; more...
    Cancer Discovery (2018)

    Fulltext@MSK | Save
  • A phase 1 trial of vadastuximab talirine combined with hypomethylating agents in patients with CD33-positive AML
    Journal Article

    Fathi, A. T.; Erba, H. P.; Lancet, J. E.; Stein, E. M.; Ravandi, F.; Faderl, S.; Walter, R. B.; Advani, A. S.; DeAngelo, D. J.; Kovacsovics, T. J.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Strategies for glycosylation-based immunotargeting of MUC16
    Meeting Abstract

    Spriggs, D.; O'Cearbhaill, R.; Yeku, O.; Stasenko, M.; Rao, T. D.; Brentjens, R.
    Clinical Cancer Research (2018)

    Fulltext@MSK | Save
  • Differentiation syndrome associated with enasidenib, a selective inhibitor of mutant isocitrate dehydrogenase 2 analysis of a phase 1/2 study
    Journal Article

    Fathi, A. T.; DiNardo, C. D.; Kline, I.; Kenvin, L.; Gupta, I.; Attar, E. C.; Stein, E. M.; de Botton, S.; for the AG221-C-001 Study Investigators
    JAMA Oncology (2018)

    Fulltext@MSK | Save
  • Cytokine release syndrome grade as a predictive marker for infections in patients with relapsed or refractory B-cell acute lymphoblastic leukemia treated with chimeric antigen receptor T cells
    Journal Article

    Park, J. H.; Romero, F. A.; Taur, Y.; Sadelain, M.; Brentjens, R. J.; Hohl, T. M.; Seo, S. K.
    Clinical Infectious Diseases (2018)

    Fulltext@MSK | Save
  • Clonal heterogeneity of acute myeloid leukemia treated with the IDH2 inhibitor enasidenib
    Journal Article

    Quek, L.; David, M. D.; Kennedy, A.; Metzner, M.; Amatangelo, M.; Shih, A.; Stoilova, B.; Quivoron, C.; Heiblig, M.; Willekens, C.; more...
    Nature Medicine (2018)

    Fulltext@MSK | Save
  • JAK/MAP kinase pathway activation and TP53 mutations in acute leukemia with megakaryocytic and erythroid differentiation
    Journal Article

    Xiao, W.; Rampal, R.; Zhang, Y.; Cimera, R.; Jungbluth, A. A.; Arcila, M.; Roshal, M.; Park, D. C.
    Leukemia (2018)

    Fulltext@MSK | Save
  • Autologous CD19-Targeted CAR T cells in patients with residual CLL following initial purine analog-based therapy
    Journal Article

    Geyer, M. B.; Rivière, I.; Sénéchal, B.; Wang, X.; Wang, Y.; Purdon, T. J.; Hsu, M.; Devlin, S. M.; Halton, E.; Lamanna, N.; more...
    Molecular Therapy (2018)

    Fulltext@MSK | Save
  • CAR T cell therapy for multiple myeloma: Where are we now and where are we headed?
    Journal Article

    Ghosh, A.; Mailankody, S.; Giralt, S. A.; Landgren, C. O.; Smith, E. L.; Brentjens, R. J.
    Leukemia and Lymphoma (2018)

    Fulltext@MSK | Save